These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16109979)

  • 1. Using protein microarray as a diagnostic assay for non-small cell lung cancer.
    Zhong L; Hidalgo GE; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
    Am J Respir Crit Care Med; 2005 Nov; 172(10):1308-14. PubMed ID: 16109979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
    Zhong L; Coe SP; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
    J Thorac Oncol; 2006 Jul; 1(6):513-9. PubMed ID: 17409910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
    Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
    Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies as potential biomarkers for breast cancer.
    Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
    Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer.
    Zhong L; Peng X; Hidalgo GE; Doherty DE; Stromberg AJ; Hirschowitz EA
    Proteomics; 2004 Apr; 4(4):1216-25. PubMed ID: 15049001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
    Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
    Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer.
    Khattar NH; Coe-Atkinson SP; Stromberg AJ; Jett JR; Hirschowitz EA
    Cancer Biol Ther; 2010 Aug; 10(3):267-72. PubMed ID: 20543565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
    Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
    J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
    Sheu CC; Yu YP; Tsai JR; Chang MY; Lin SR; Hwang JJ; Chong IW
    Int J Cancer; 2006 Sep; 119(6):1419-26. PubMed ID: 16642481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer.
    Schneider J; Bitterlich N; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Int J Clin Oncol; 2002 Jun; 7(3):145-51. PubMed ID: 12109515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
    Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
    Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer.
    Mroczko B; Szmitkowski M; Niklinski J
    Clin Chem Lab Med; 1999 Oct; 37(10):959-62. PubMed ID: 10616749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of lung cancer in silicosis patients using a tumor-marker panel.
    Schneider J
    Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.